Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Veranex News

2 min read

Veranex Unveils MedTech’s First Innovation CRO (iCRO)—Redefining R&D in a Capital-Tight Market

Raleigh, N.C. — 15 July 2025 — Veranex, a global provider of product development and contract research services, today introduced the industry’s first Innovation CRO (iCRO)—an integrated development and research platform engineered to move medical...

Read More

2 min read

Veranex Appoints Morwan Choli, PhD as Senior Vice President of Global Regulatory Affairs and Quality

Raleigh, NC – MAY 27, 2025 – Veranex, the only truly comprehensive global MedTech services provider, proudly announces the appointment of Morwan...

Read More

3 min read

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization MedTech Services Company

RALEIGH, N.C.; June 16, 2021 – Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to...

Read More

1 min read

Quartesian Signs Global Medical Technology Company to Multiyear Clinical Data Management Services Agreement

PRINCETON, N.J., April 13, 2021 — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and medical device...

Read More

1 min read

Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial

PRINCETON, N.J., June 16, 2020 /PRNewswire/ — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and...

Read More

1 min read

Veranex Announces Acquisition of Experien Group

RALEIGH, N.C.; August 3, 2021 – Veranex the first concept-to-commercialization global service provider dedicated to the medtech industry, today...

Read More

2 min read

Industry Veterans and Experts Join Veranex

RALEIGH, N.C.; May 24, 2022 – Veranex today announced the expansion of the company’s leadership team with the additions of Patricia Deverka as Senior...

Read More

2 min read

Veranex Announces Acquisition of IMMR

RALEIGH, N.C.; Oct. 12, 2021 – Veranex, the first concept-to-commercialization global service provider dedicated to the MedTech industry, today...

Read More

2 min read

Sixth Acquisition Extends Veranex Lead in MedTech Industry Services

Veranex expands global capabilities for human-centered design, innovation, and strategy

Read More

2 min read

Veranex Announces Strategic Investments From Accelmed Partners and Lauxera Capital Partners

RALEIGH, N.C.; May 19, 2022 – Veranex — the only global, tech-enabled product development services provider focused on the medical technology...

Read More